Zhongke Yuhang and Guangzhou Laboratory are jointly developing a
space-pharmaceutical payload and plan to run scenario validation. The first
payload is scheduled for suborbital flight on the Lihong-2 reusable launcher in
Q1 2027 to conduct protein and small-molecule drug crystallization experiments
and to perform preliminary technology validation of space-pharmaceutical
equipment.
